Stay updated with breaking news from Vstm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Rating) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price […]
StockNews.com initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently commented on VSTM. HC Wainwright reiterated a buy rating and set a $3.00 price target […]
Equities research analysts at StockNews.com began coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Several other equities analysts also recently commented on VSTM. Mizuho began coverage on shares of Verastem in a research note […]
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Rating) have earned a consensus rating of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among […]
Mizuho initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research report sent to investors on Wednesday morning, The Fly reports. The firm issued a neutral rating and a $2.00 price objective on the biopharmaceutical company’s stock. Several other research firms have also recently commented on VSTM. Royal Bank of Canada reaffirmed […]